Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 13-24 of 23,847
Other study type icon
RecruitingISRCTN71913555

3D-printed cardiac models for patient evaluation for congenital heart disease

This observational study is following people with Parents anxiety and procedural understanding with children suffering from CHD or Circulatory System to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Germany
AnxietyOtherFrom 18 Years to 60 Years
Countries
Germany
Sponsor
LMU Klinikum
Condition
Anxiety
Device study icon
RecruitingNCT05680220

40 Hz Light Neurostimulation for people with Depression (FELIX)

This study is comparing Neurostimulation System (NSS): Active Setting with Sham Neurostimulation System (NSS) for people with depression or Treatment Resistant Depression. Participants receive Neurostimulation System (NSS): Active Setting or Sham Neurostimulation System (NSS) and complete study visits and assessments.

In Copenhagen
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 75 Years
Countries
Denmark
Sponsor
Klaus Martiny
Condition
Depression
Device study icon
RecruitingNCT06907420

40 Hz Visual Stimulation as an Intervention in Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Munich
SchizophreniaDeviceOver 18 Years
Countries
Germany
Sponsor
Technical University of Munich
Condition
Schizophrenia
Drug study icon
RecruitingNCT05452772

5-HT2A Agonist Psilocybin in the Treatment of Addiction

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
AddictionDrugA study involving a medication or substance.Over 21 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Addiction
Drug study icon
RecruitingNCT05895747

5-HTP and Creatine for Depression R33 Phase

This study is comparing Low Dose 5-hydroxytryptophan with placebo for people with depression. Participants receive Low Dose 5-hydroxytryptophan or placebo and complete study visits and assessments.

In Salt Lake City
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Utah
Condition
Depression
Drug study icon
RecruitingNCT06412315

7T Amygdala and Citalopram Study

This study is comparing Citalopram with placebo for people with Emotional Processing, Cognition, or depression. Participants receive Citalopram or placebo and complete study visits and assessments.

In Oxford
DepressionDrugFrom 18 Years to 40 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
Other study type icon
RecruitingISRCTN49123202

Effectiveness of individual psychological intervention in depression

This study is recruiting in the United Kingdom. It is testing individual psychological intervention for depression.

In United Kingdom
Depression, AnxietyOther
Countries
United Kingdom
Sponsor
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Condition
Depression, Anxiety
Drug study icon
RecruitingNCT07493551

A Bioequivalence Study of PP3M in people with Schizophrenia

This study is looking at whether Paliperidone Palmitate Injection (3M) can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

In Beijing
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.